- Donate
- Understanding Rare Disease
- Living with a Rare Disease
- Community Support
- Advancing Research
- Driving Policy
- Get Involved
- Rare Disease News
- Resource Library
- About Us
- For Clinicians & Researchers
- For Patient Organizations
Last updated: April 10, 2009
Years published: 1997, 2001, 2003, 2009
NORD gratefully acknowledges Shashikant Kulkarni, PhD, Director of CytoGenomics and Molecular Pathology, Director of Clinical & Molecular Cytogenetics, Department of Pathology, Washington University School of Medicine, for assistance in the preparation of this report.
Chromosome 15, Distal Trisomy 15q is an extremely rare chromosomal disorder in which the end (distal) portion of the long arm (q) of the 15th chromosome (15q) appears three times (trisomy) rather than twice in cells of the body. The disorder is characterized by growth delays before and/or after birth (prenatal and/or postnatal growth retardation); mental retardation; and/or distinctive malformations of the head and facial (craniofacial) area. Additional abnormalities typically include an unusually short neck; malformations of the fingers and/or toes; abnormal sideways curvature of the spine (scoliosis) and/or other skeletal malformations; genital abnormalities, particularly in affected males; and/or, in some cases, heart (cardiac) defects. The range and severity of symptoms and physical findings may vary from case to case, depending upon the length and location of the duplicated portion of chromosome 15q. In most cases, Chromosome 15, Distal Trisomy 15q is due to a chromosomal balanced translocation in one of the parents.
In individuals with Chromosome 15, Distal Trisomy 15q, an extremely rare chromosomal disorder, the end (distal) portion of the long arm (q) of chromosome 15 (15q) is duplicated (trisomic). Symptoms and physical characteristics associated with the disorder may vary in range and severity, depending upon the exact size and location of the duplicated portion of chromosome 15q.
In some cases, Chromosome 15, Distal Trisomy 15q may be characterized by abnormally slow growth before and/or after birth (prenatal and/or postnatal growth retardation) . In addition, many affected infants experience swallowing and feeding difficulties that may be due to the presence of certain malformations of the head and facial (craniofacial) area. Such feeding and swallowing difficulties may result in or contribute to an affected infantโs failure to grow or gain weight at the expected rate (failure to thrive). However, in certain rare cases (i.e., trisomy 15q25-qter), affected individuals may exhibit abnormally tall stature. (For more information on trisomy 15q25-qter, see the โCausesโ section below.)
Most infants with Chromosome 15, Distal Trisomy 15q also exhibit abnormally diminished muscle tone (hypotonia). In addition, most affected infants and children have severe to profound mental retardation. However, in rare cases (i.e., trisomy 15q25-qter), only mild mental retardation may be present.
Many infants and children with the disorder have characteristic malformations of the head and facial (craniofacial) area. In some cases, the fibrous joints between certain bones in the skull (sagittal sutures) close prematurely (craniosynostosis), causing the head to appear abnormally long and narrow (dolichocephaly). In addition, in many cases, the head may appear abnormally small (microcephaly), with abnormal bulging (prominence) of the back of the head (occiput) and a sloping forehead. In addition, the face may appear dissimilar from one side to the other (facial asymmetry). In rare cases (i.e., trisomy 15q25-qter), affected infants may have hydrocephalus, a condition characterized by inhibition of the normal flow of cerebrospinal fluid (CSF) within and abnormal widening (dilatation) of the cerebral spaces of the brain (ventricles), causing accumulation of CSF in the skull and potentially increased pressure on brain tissue.
Additional craniofacial malformations typically associated with the disorder may include downwardly slanting, short, and/or narrow eyelid folds (palpebral fissures); drooping of the upper eyelids (ptosis); an abnormally large, prominent, and/or rounded (bulbous) nose with a broad nasal bridge; and/or an unusually small, triangular mouth. In addition, many affected infants and children may have an abnormally long groove in the upper lip (philtrum), a crease in the center (midline) of the lower lip, a highly arched roof of the mouth (palate), an unusually small jaw (micrognathia), and/or abnormally round, โpuffyโ cheeks. In some cases, the ears may be abnormally large, low-set, and/or malformed (dysplastic). In addition, the neck may be short and/or webbed, which, in some cases, may be due to malformations of certain bones in the upper portion of the spine (cervical vertebrae). Approximately one third of affected infants and children may also experience episodes of uncontrolled electrical disturbances in the brain (seizures).
In addition, most infants and children with Chromosome 15, Distal Trisomy 15q have skeletal abnormalities affecting the fingers, toes, chest (thorax), and/or spine. Affected individuals may have unusually long, thin fingers and/or toes (arachnodactyly), permanently flexed fingers (camptodactyly), and/or excessive extension (hyperextension) of the thumbs. In addition, the joints of the hands and feet may become fixed in a permanently flexed position (joint contractures). Affected individuals may also have side-to-side curvature of the spine (scoliosis) and/or abnormal depression of the sternum, the bone forming the center of the chest (โfunnel chestโ or pectus excavatum).
In many cases, individuals with Chromosome 15, Distal Trisomy 15q also have genital abnormalities. In males, such abnormalities may include failure of the testes to descend into the scrotum (cryptorchidism) and/or low levels of testicular function (hypogonadism), resulting in delayed development of secondary sexual characteristics (i.e., deepening of the voice, characteristic hair growth patterns, sudden increase in growth and development of the testes and scrotum, etc.). Some affected females may exhibit underdevelopment of the two long folds of skin on either side of the vaginal opening (labia majora).
In addition, many affected infants may have abnormalities of the heart (congenital heart defects) and/or may exhibit an increased susceptibility to recurrent respiratory tract infections. In some cases, swallowing and feeding difficulties may cause food to be inhaled (aspirated) into the lungs, which may result in severe lung infections (aspiration pneumonia). In some cases, such abnormalities may result in life-threatening complications.
Chromosome 15, Distal Trisomy 15q is an extremely rare chromosomal disorder in which the end (distal) portion of the long arm (q) of the 15th chromosome appears three times (trisomy) rather than twice in cells of the body. Chromosomes are found in the nucleus of all body cells except red blood cells. They carry the genetic characteristics of each individual. Pairs of human chromosomes are numbered from 1 through 22, with an unequal 23rd pair of X and Y chromosomes for males and two X chromosomes for females. Each chromosome has a short arm designated as โpโ and a long arm identified by the letter โq.โ Chromosomes are further subdivided into bands that are numbered. For example, โ15q21โ refers to band 21 on the long arm of chromosome 15.
The duplication of the distal portion of chromosome 15q is responsible for the symptoms and physical features that characterize this disorder. The range and severity of associated abnormalities may depend upon the exact length and location of the duplicated portion of chromosome 15q.
According to investigators, in those with Chromosome 15, Distal Trisomy 15q, the duplicated portion of 15q usually begins between bands 15q21 and 15q23 (breakpoint) and extends toward the end or โterminalโ portion of chromosome 15q (qter). In rare cases, the breakpoint has occurred at band 15q25. According to the medical literature, although individuals with trisomy 15q25-qter have many of the characteristic abnormalities typically associated with the disorder, there may be some differences. (For further information, please see the โSymptomsโ section above.) A few families have also been described in which the breakpoint has occurred at band 15q15.
In most cases, Chromosome 15, Distal Trisomy 15q is due to a chromosomal โbalanced translocationโ in one of the parents. Translocations occur when regions of certain chromosomes break off and are rearranged, resulting in shifting of genetic material and an altered set of chromosomes. A translocation is balanced if it consists of an altered but balanced set of chromosomes. If a chromosomal rearrangement is balanced, meaning that it consists of an altered but balanced amount of genetic material, it is usually harmless to the carrier. However, such a chromosomal rearrangement may be associated with an increased risk of unbalanced chromosome inheritance in the carrierโs offspring. Chromosomal analysis and genetic counseling are typically recommended for parents of an affected child to help confirm or exclude a chromosomal rearrangement in one of the parents.
According to the medical literature, in the case of parental balanced translocations that result in Distal Trisomy 15q, the second chromosome involved with chromosome 15q has varied from case to case; however, symptoms and findings characteristically associated with the disorder (clinical phenotype) appear consistent.
Chromosome 15, Distal Trisomy 15q is an extremely rare chromosomal disorder that is thought to affect males approximately twice as often as females. Since the disorder was originally described in the medical literature in 1974 (A. Fujimoto), more than 30 cases have been reported in the literature. The majority of symptoms and physical features associated with the disorder are apparent at birth.
In some cases, the diagnosis of Chromosome 15, Distal Trisomy 15q may be determined before birth (prenatally) by specialized tests such as ultrasound, amniocentesis, and/or chorionic villus sampling (CVS. Ultrasound studies may reveal characteristic findings that suggest a chromosomal disorder or other developmental abnormalities in the fetus. During amniocentesis, a sample of fluid that surrounds the developing fetus is removed and studied. During chorionic villus sampling, a tissue sample is removed from a portion of the placenta. Chromosomal studies performed on this fluid or tissue sample may reveal the presence of Distal Trisomy 15q.
Chromosome 15, Distal Trisomy 15q may also be diagnosed and/or confirmed after birth (postnatally) based upon a thorough clinical evaluation, identification of characteristic physical findings, and chromosomal studies.
Certain specific abnormalities that may occur in association with Distal Trisomy 15q may be detected and/or confirmed by specialized imaging studies and/or additional tests. For example, specialized x-ray studies may be used to confirm and/or characterize certain skeletal abnormalities potentially associated with the disorder (e.g., dolichocephaly, micrognathia, cervical vertebral abnormalities, scoliosis). Congenital heart defects potentially associated with Chromosome 15, Distal Trisomy 15q may be detected, confirmed, and/or characterized by a thorough clinical evaluation and specialized tests that allow physicians to evaluate the structure and function of the heart (e.g., x-ray studies, electrocardiogram [EKG] echocardiogram, cardiac catherization). In addition, in some cases, electroencephalography (EEG), which records the brain's electrical impulses, may reveal brain wave patterns that are characteristic of certain types of seizure activity.
Treatment
The treatment of Chromosome 15, Distal Trisomy 15q is directed toward the specific symptoms that are apparent in each individual. Treatment may require the coordinated efforts of a team of specialists. Pediatricians, surgeons, physicians who specialize in diagnosing and treating disorders of the skeletal system (orthopedists), and/or other health care professionals may need to systematically and comprehensively plan an affected child's treatment.
The treatment of Chromosome 15, Distal Trisomy 15q may include surgical repair of certain malformations. In some cases, surgery may be performed to correct congenital heart defects, craniofacial malformations, webbing of the neck, flexion contractures, abnormalities of the hands and/or feet, genital malformations, and/or other abnormalities that may be associated with the disorder. The surgical procedures performed will depend upon the severity and location of the anatomical abnormalities and their associated symptoms.
In some cases, abnormalities involving the joints, tendons, muscles, and bones (e.g., flexion contractures, malformations of the fingers and/or toes, scoliosis) may be treated with orthopedic techniques potentially in combination with surgery. Physical therapy may also be prescribed to help improve coordination of movements (mobility).
In addition, physicians may recommend preventive measures for affected infants and children who may be prone to repeated respiratory infections. Physicians may also regularly monitor affected individuals for such infections to ensure early detection and appropriate, prompt treatment.
Early intervention is important to ensure that children with Chromosome 15, Distal Trisomy 15q reach their potential. Special services that may be beneficial to affected children may include special remedial education, special social support, and/or other medical, social, and/or vocational services.
Genetic counseling will be of benefit for families of children with Chromosome 15, Distal Trisomy 15q. Chromosomal studies are necessary to determine whether a balanced translocation is present in one of the parents. Other treatment for the disorder is symptomatic and supportive.
Information on current clinical trials is posted on the Internet at www.clinicaltrials.gov. All studies receiving U.S. government funding, and some supported by private industry, are posted on this government web site.
For information about clinical trials being conducted at the NIH Clinical Center in Bethesda, MD, contact the NIH Patient Recruitment Office:
Tollfree: (800) 411-1222
TTY: (866) 411-1010
Email: [email protected]
For information about clinical trials sponsored by private sources, contact:
www.centerwatch.com
(Please note that some of these organizations may provide information concerning certain conditions potentially associated with this disorder [e.g., craniofacial malformations, congenital heart defects, seizures, mental retardation, etc.].)
TEXTBOOKS
Jones KL. Smithโs Recognizable Patterns of Human Malformation. 5th ed. Philadelphia, PA: W.B. Saunders Company; 1997:62-63.
Buyse ML. Birth Defects Encyclopedia. Dover, MA: Blackwell Scientific Publications, Inc.; 1990:374-75.
Gorlin RJ, et al., eds. Syndromes of the Head and Neck. 3rd ed. New York, NY: Oxford University Press; 1990:90.
JOURNAL ARTICLES
Cora T, et al. A partial trisomy 15q due to 15;17 translocation detected by conventional cytogenetic and FISH techniques. Genet Couns. 2000;11:25-32.
Zollino M, et al. Partial duplication of the long arm of chromosome 15: confirmation of a causative role in craniosynostosis and definition of a 15q25-qter trisomy syndrome. Am J Med Genet. 1999;87:391-94.
Fryns JP, et al. The fetal phenotype in 15q2 duplication. Ann Genet. 1988;31:123-25.
Nazarenko SA, et al. Trisomy of the distal 15q region due to familial balanced translocation t(15;16) (q24;p13) and unusual mosaicism in the mother of the proband. Tsitol Genet. 1987;21:434-37.
Lacro RV, et al. Duplication of distal 15q: report of five new cases from two different translocation kindreds. Am J Med Genet. 1987;26:719-28.
Garcia-Cruz D, et al. Trisomy 15q23โ-qter due to a de novo t(11;15) (q25;q23) and assignment of the critical segment. Ann Genet. 1985;28:193-96.
Orye E, et al. Mosaic and non-mosaic trisomy 15q2. Ann Genet. 1985;28:58-60.
Schnatterly P, et al. Distal 15q trisomy: phenotypic comparison of nine cases in an extended family. Am J Hum Genet. 1984;36:444-51.
Tzancheva M, et al. Two familial cases with trisomy 15q dist due to a rcp (5;15) (p14;q21). Hum Genet. 1981;56:275-77.
Gregoire MJ, et al. Duplication 15q22 to 15qter and its phenotypic expression. Hum Genet. 1981;59:429-33.
Castel Y, et al. Partial trisomy 15q due to maternal translocation t (7;15) (q35;14). Ann Genet. 1976;19:15-19.
Fujimoto A, et al. Inherited partial duplication of chromosome no. 15. J Med Genet. 1974;11:287-91.
NORD strives to open new assistance programs as funding allows. If we donโt have a program for you now, please continue to check back with us.
NORD and MedicAlert Foundation have teamed up on a new program to provide protection to rare disease patients in emergency situations.
Learn more https://rarediseases.org/patient-assistance-programs/medicalert-assistance-program/Ensuring that patients and caregivers are armed with the tools they need to live their best lives while managing their rare condition is a vital part of NORDโs mission.
Learn more https://rarediseases.org/patient-assistance-programs/rare-disease-educational-support/This first-of-its-kind assistance program is designed for caregivers of a child or adult diagnosed with a rare disorder.
Learn more https://rarediseases.org/patient-assistance-programs/caregiver-respite/No patient organizations found related to this disease state.
The information provided on this page is for informational purposes only. The National Organization for Rare Disorders (NORD) does not endorse the information presented. The content has been gathered in partnership with the MONDO Disease Ontology. Please consult with a healthcare professional for medical advice and treatment.
The Genetic and Rare Diseases Information Center (GARD) has information and resources for patients, caregivers, and families that may be helpful before and after diagnosis of this condition. GARD is a program of the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH).
View reportOrphanet has a summary about this condition that may include information on the diagnosis, care, and treatment as well as other resources. Some of the information and resources are available in languages other than English. The summary may include medical terms, so we encourage you to share and discuss this information with your doctor. Orphanet is the French National Institute for Health and Medical Research and the Health Programme of the European Union.
View report
Your donation will help more than 30 million Americans with a rare disease navigate their diagnosis, receive financial assistance, and access the care and support they deserve. Make your tax-deductible gift today!